Related Experiment Videos
Kukoamine A analogs with lipoxygenase inhibitory activity
Dimitra Hadjipavlou-Litina1, Thomas Garnelis, Constantinos M Athanassopoulos
1Department of Pharmaceutical Chemistry, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece. hadjipav@pharm.auth.gr
Journal of Enzyme Inhibition and Medicinal Chemistry
|September 24, 2009
Summary
Kukoamine A (KukA), a spermine conjugate, exhibits significant antioxidant and anti-inflammatory properties. This compound and its analogs effectively inhibit lipoxygenase and lipid peroxidation, showing potential therapeutic applications.
Area of Science:
- Natural Product Chemistry
- Pharmacology
- Biochemistry
Background:
- Kukoamine A (KukA) is a conjugate of spermine (SPM) and dihydrocaffeic acid (DHCA) with known biological activities.
- Investigating structure-activity relationships of KukA analogs is crucial for understanding its therapeutic potential.
Purpose of the Study:
- To synthesize and evaluate regioisomers and analogs of Kukoamine A.
- To assess their antioxidant, anti-lipoxygenase, and anti-lipid peroxidation activities.
- To determine the in vivo anti-inflammatory effects of potent KukA derivatives.
Main Methods:
- Synthesis of Kukoamine A regioisomers and analogs.
- Evaluation of antioxidant activity using DPPH free radical scavenging assay.
- Assay of soybean lipoxygenase (LOX) inhibitory activity.
- Measurement of lipid peroxidation inhibition.
- In vivo anti-inflammatory testing using carrageenan-induced rat paw edema.
Main Results:
- Kukoamine A and its analogs demonstrated a wide range of antioxidant activity (5-97.5%).
- Kukoamine A significantly inhibited LOX with an IC(50) of 9.5 microM.
- All tested analogs inhibited lipid peroxidation (11-100%).
- Kukoamine A and analog 3 showed comparable anti-inflammatory activity to indomethacin in vivo.
Conclusions:
- Kukoamine A and its analogs possess significant antioxidant, anti-lipoxygenase, and anti-lipid peroxidation properties.
- Structural modifications influence the biological activity of Kukoamine A.
- Kukoamine A and its derivatives represent promising candidates for anti-inflammatory drug development.
Related Concept Videos
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:30Local Anesthetics: Chemistry and Structure-Activity Relationship
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
01:17Oxidation of Phenols to Quinones
In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...